How does ear nerve stimulation device work?

The device uses transcutaneous autonomic neuromodulation. A handheld device by Afferent Medical Solutions uses two small clips positioned on the tragus flap cartilage in front of the ear canal to deliver mild electrical signals to autonomic nerves controlling heart rate and blood pressure. Patients can use it at home without clinic visits or surgery.

What did SCRATCH-HTN trial find?

The SCRATCH-HTN trial enrolled 63 people with uncontrolled hypertension already taking at least one medication. Treatment was safe, generally comfortable and practical for home use, but researchers found no statistically significant difference between active stimulation and sham device across the entire population.

Why were results promising in severe hypertension?

A prespecified subgroup analysis showed greater blood pressure reduction among participants with more severe hypertension who received active stimulation, suggesting the technique may work better for difficult-to-control blood pressure, requiring confirmation in larger studies.

Is the device safe and practical for home use?

Researchers reported treatment was safe and generally comfortable, with participants following the prescribed schedule of 30 minutes daily for two weeks then once per week, suggesting practical regular home use.

When will it be widely available?

Findings represent an early step rather than proof of an effective treatment. Larger clinical trials are essential to confirm effectiveness before it provides a cheap, scalable solution for millions with hypertension.

Cancer Awareness

Cancer Awareness DISEASES

Processed Meat Raises Stomach and Esophageal Cancer Risk

News BureauSeptember 13, 2026September 13, 2026

International Journal of Cancer study of 450,112 people tracked 14.1 years finds 30g more processed meat daily linked to 9% higher gastric cancer and 13% higher esophageal adenocarcinoma risk.

Cancer Awareness

Breast Cancer Spread Could Be Stopped

AbhiramSeptember 13, 2026September 13, 2026

Adelaide University and Olivia Newton-John Institute study in EMBO Molecular Medicine finds low miR-342 drives TNBC metastasis, palbociclib reduces lung and bone spread.